Literature DB >> 21844802

Microsporidiosis: not just in AIDS patients.

Elizabeth S Didier1, Louis M Weiss.   

Abstract

PURPOSE OF REVIEW: Microsporidia have emerged as causes of opportunistic infections associated with diarrhea and wasting in AIDS patients. This review describes recent reports of microsporidiosis in HIV-infected individuals and the growing awareness of microsporidiosis in non-HIV-infected populations. RECENT
FINDINGS: Microsporidia were only rarely recognized as causes of disease in humans until the AIDS pandemic. Implementation of combination antiretroviral therapy (cART) to curtail HIV replication and restore immune status drastically reduced the occurrence of opportunistic infections, including those due to microsporidia, in HIV-infected individuals. In developing countries where cART is not always accessible, microsporidiosis continues to be problematic. Improvement of diagnostic methods over the previous 25 years led to identification of several new species of microsporidia, many of which disseminate from enteric to systemic sites of infection and contribute to some unexpected lesions. Among non-HIV-infected but immune-suppressed individuals, microsporidia have infected organ transplant recipients, children, the elderly, and patients with malignant disease and diabetes. In otherwise healthy immune-competent HIV seronegative populations, self-limiting diarrhea occurred in travelers and as a result of a foodborne outbreak associated with contaminated cucumbers. Keratitis due to microsporidiosis has become problematic and a recent longitudinal evaluation demonstrated that non-HIV-infected individuals seropositive for microsporidia who had no clinical signs continued to intermittently shed organisms in feces and urine.
SUMMARY: Greater awareness and implementation of better diagnostic methods are demonstrating that microsporidia contribute to a wide range of clinical syndromes in HIV-infected and non-HIV-infected people. As such, microsporidia should be considered in differential diagnoses if no other cause can be defined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844802      PMCID: PMC3416021          DOI: 10.1097/QCO.0b013e32834aa152

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  42 in total

1.  Intestinal parasites infections in hospitalized AIDS patients in Kinshasa, Democratic Republic of Congo.

Authors:  R Wumba; B Longo-Mbenza; M Mandina; Wobin T Odio; S Biligui; J Sala; J Breton; M Thellier
Journal:  Parasite       Date:  2010-12       Impact factor: 3.000

2.  Evaluation of gram-chromotrope kinyoun staining technique: its effectiveness in detecting microsporidial spores in fecal specimens.

Authors:  Fatmah M Salleh; Abdulsalam M Al-Mekhlafi; Anisah Nordin; 'Azlin M Yasin; Hesham M Al-Mekhlafi; Norhayati Moktar
Journal:  Diagn Microbiol Infect Dis       Date:  2011-01       Impact factor: 2.803

Review 3.  Microsporidial keratitis: need for increased awareness.

Authors:  Savitri Sharma; Sujata Das; Joveeta Joseph; Geeta K Vemuganti; Somasheila Murthy
Journal:  Surv Ophthalmol       Date:  2010-11-11       Impact factor: 6.048

4.  Chronic microsporidial enteritis in a missionary from Mozambique.

Authors:  James R Palmieri; Shaadi F Elswaifi; David S Lindsay; Gretchen Junko; Cathy Callahan
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

5.  PCR for the diagnosis and species identification of microsporidia in patients with keratitis.

Authors:  A K Reddy; P K Balne; K Gaje; P Garg
Journal:  Clin Microbiol Infect       Date:  2011-03       Impact factor: 8.067

6.  A preliminary study on the prevalence of parasitic infections in immunocompromised children.

Authors:  Sanaa N Antonios; Osama A Tolba; Ahmad A Othman; Marwa A Saad
Journal:  J Egypt Soc Parasitol       Date:  2010-12

7.  Unapparent microsporidial infection among immunocompetent humans in the Czech Republic.

Authors:  Bohumil Sak; Daniel Brady; Markéta Pelikánová; Dana Květoňová; Michael Rost; Martin Kostka; Věra Tolarová; Zuzana Hůzová; Martin Kváč
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

8.  Wealth and its associations with enteric parasitic infections in a low-income community in Peru: use of principal component analysis.

Authors:  Shantanu Nundy; Robert H Gilman; Lihua Xiao; Lilia Cabrera; Rosa Cama; Ynes R Ortega; Geoffrey Kahn; Vitaliano A Cama
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 9.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

10.  Multiplex PCR detection of waterborne intestinal protozoa: microsporidia, Cyclospora, and Cryptosporidium.

Authors:  Seung-Hyun Lee; Migyo Joung; Sejoung Yoon; Kyoungjin Choi; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2010-12-16       Impact factor: 1.341

View more
  100 in total

1.  A new and highly divergent Enterocytozoon bieneusi genotype isolated from a renal transplant recipient.

Authors:  Christelle Pomares; Monica Santín; Michel Miegeville; Anne Espern; Laetitia Albano; Pierre Marty; Florent Morio
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

2.  Encephalitozoon cuniculi-Associated Equine Encephalitis: A Case Report.

Authors:  Jennifer A Hollyer; Eamon McGuinness; Lisa C Bowers; Elizabeth S Didier; Chiara Giudice; Daniel P Perl; Ursula Fogarty
Journal:  J Equine Vet Sci       Date:  2014-09-16       Impact factor: 1.583

3.  Infection patterns, clinical significance, and genetic characteristics of Enterocytozoon bieneusi and Giardia duodenalis in dairy cattle in Jiangsu, China.

Authors:  Rui Wang; Na Li; Wen Jiang; Yaqiong Guo; Xiaolan Wang; Yue Jin; Yaoyu Feng; Lihua Xiao
Journal:  Parasitol Res       Date:  2019-08-16       Impact factor: 2.289

4.  Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition.

Authors:  Rajarshi Bhadra; Magali M Moretto; Julio C Castillo; Constantinos Petrovas; Sara Ferrando-Martinez; Upasana Shokal; Manuel Leal; Richard A Koup; Ioannis Eleftherianos; Imtiaz A Khan
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

5.  Genetic diversity in Enterocytozoon bieneusi isolates from dogs and cats in China: host specificity and public health implications.

Authors:  Md Robiul Karim; Haiju Dong; Fuchang Yu; Fuchun Jian; Longxian Zhang; Rongjun Wang; Sumei Zhang; Farzana Islam Rume; Changshen Ning; Lihua Xiao
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

6.  Error-prone protein synthesis in parasites with the smallest eukaryotic genome.

Authors:  Sergey V Melnikov; Keith D Rivera; Denis Ostapenko; Arthur Makarenko; Neil D Sanscrainte; James J Becnel; Mark J Solomon; Catherine Texier; Darryl J Pappin; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

7.  The small GTPase RAB-11 directs polarized exocytosis of the intracellular pathogen N. parisii for fecal-oral transmission from C. elegans.

Authors:  Suzannah C Szumowski; Michael R Botts; John J Popovich; Margery G Smelkinson; Emily R Troemel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

8.  Prevalence and Molecular Characterization of Enterocytozoon bieneusi among Pigs in Chonburi Province, Eastern Thailand.

Authors:  Umaporn Thathaisong; Suradej Siripattanapipong; Saovanee Leelayoova; Mathirut Mungthin
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 9.  MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Authors:  Siobhan Sutcliffe; Angelo M De Marzo; Karen S Sfanos; Martin Laurence
Journal:  Prostate       Date:  2014-01-24       Impact factor: 4.104

Review 10.  Caenorhabditis elegans as a model for intracellular pathogen infection.

Authors:  Keir M Balla; Emily R Troemel
Journal:  Cell Microbiol       Date:  2013-05-13       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.